Semaglutide pricing at medspas varies widely because the source matters: branded Ozempic or Wegovy carry manufacturer list prices, while compounded versions offer lower acquisition costs but carry regulatory and liability nuance. Most medspas offering semaglutide use compounded formulations, which wholesale for $100–$300 per month depending on dose and compounding pharmacy, then mark up 100–200% to retail prices of $200–$600 per month. Branded Wegovy (the GLP-1 indicated for weight loss) retails around $1,300–$1,500 per month at pharmacy, but few medspas stock it; those that do typically charge $1,200–$1,400 to remain competitive or absorb some margin to justify the premium positioning.
Market
Semaglutide Pricing at Medspas: Compounded vs. Branded and What Patients Actually Pay
Medspa semaglutide costs range from $200–$600+ per month depending on dose, formulation source, and markup strategy—here's how the margin model works and what drives patient pricing.
